
2024 ASCO® Annual Meeting Insights Hub
Meeting coverage & Vumedi’s exclusive highlights, all in one place.
ASCO® 2024 Insights: "Lenvatinib + Pembro vs. Sunitinib in aRCC - Patterns of Progression and Subsequent Therapy in the CLEAR Trial"
By
2024 ASCO® Annual Meeting Insights Hub
FEATURING
Viktor Grünwald
By
2024 ASCO® Annual Meeting Insights Hub
FEATURING
Viktor Grünwald
125 views
June 11, 2024
Chapters
CLEAR Study: Len-Pem vs. Sunitinib Efficacy
00:00
Subsequent Therapies & Tumor Burden Analysis
01:49
Comments 0
Login to view comments.
Click here to Login
GU